Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimorazole in HPV-Negative Head and Neck Cancer
NCT01880359Phase 3Unknown
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jul 2014
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of nimorazole in head and neck squamous cell carcinoma (HNSCC), sponsored by European Organisation for Research and Treatment of Cancer. Status: unknown.
02
Drugs
nimorazole
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01880359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01880359.